That a neurological review is dedicated specifically to the oligodendroglioma is testimony to a decade of progress. The unique molecular features and chemosensitivity of the oligodendroglioma were not appreciated 10 years ago; yet today, these features merit such interest to clinicians and pathologists alike that the oligodendroglioma is separated from other types of primary brain tumors in both the laboratory and in practice.
No takes yet. Share an insight, caveat, or question.
Perry et al. (1999) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: